Insulet
PODD
#1880
Rank
C$16.17 B
Marketcap
C$233.48
Share price
2.94%
Change (1 day)
-42.97%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2026 (TTM): C$0.64 Billion

According to Insulet's latest financial reports the company's current earnings are C$2.90 Billion. In 2025 the company made an earning of C$0.56 Billion, an increase over its 2024 earnings that were of C$0.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.64 B14.43%
2025 C$0.56 B16.3%
2024 C$0.48 B36.76%
2023 C$0.35 B481.9%
2022 C$61.18 M-45.24%
2021 C$0.11 B43.35%
2020 C$77.93 M18.51%
2019 C$65.76 M41.16%
2018 C$46.58 M-711.95%
2017 -C$7.62 Million-56.85%
2016 -C$17.65 Million-79.31%
2015 -C$85.3 Million63.85%
2014 -C$52.06 Million31.04%
2013 -C$39.73 Million-21.96%
2012 -C$50.91 Million
2010 -C$48.55 Million-42.38%
2009 -C$84.27 Million-33.56%
2008 -C$0.13 Billion65.93%
2007 -C$76.44 Million209.75%
2006 -C$24.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.87 B 5,436.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$11.55 B 1,634.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
C$8.90 B 1,237.60%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
C$44.18 B 6,533.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-C$0.29 Billion-142.68%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
C$0.13 B-79.18%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
C$1.73 B 160.08%๐Ÿ‡บ๐Ÿ‡ธ USA